Roivant Sciences Ltd.
ROIV· Nasdaq
ROIVRoivant Sciences Ltd.
Filed Feb 14, 2022 · 10-Q · 45 days after period end · 0001193125-22-039433
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Revenue | $24.34M | $5.75M |
| Net Income | -$284.54M | -$261.03M |
| EPS Diluted | -$0.41 | -$0.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Roivant Sciences Ltd. · CIK 1635088 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Feb 14, 2022 · 45 d after period end
